Breast Cancer NSABP B-49

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline Based Chemotherapy Regimens for Women with Node-Positive or High-Risk NodeNegative, HER2-Negative Breast Cancer.